Matthew I. Milowsky
Impact in
- Surgery top 0.2%
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Papers in
- Surgery 187
- Bladder and Urothelial Cancer Treatments 175
- Urinary and Genital Oncology Studies 62
-
- Renal cell carcinoma treatment 37
- Prostate Cancer Treatment and Research 28
- Co-authors
- David M. Nanus (28 shared papers)Neil H. Bander (10 shared papers)Stanley J. Goldsmith (10 shared papers)Dean F. Bajorin (55 shared papers)Shankar Vallabhajosula (9 shared papers)Lale Kostakoğlu (7 shared papers)William Y. Kim (34 shared papers)Gopa Iyer (15 shared papers)
- Journals
- Journal of Clinical Oncology (98 papers)Cancer (16 papers)Annals of Oncology (14 papers)The Journal of Urology (12 papers)Clinical Genitourinary Cancer (11 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Matthew I. Milowsky
264 papers receiving 10.6k citations
Matthew I. Milowsky's Hit Papers
Peers
Comparison fields: 5 of 131
- Surgery 5.2k
- Pulmonary and Respiratory Medicine 3.0k
- Oncology 2.4k
- Urology 507
- Cancer Research 934
Countries citing papers authored by Matthew I. Milowsky
This map shows the geographic impact of Matthew I. Milowsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew I. Milowsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew I. Milowsky more than expected).
Fields of papers citing papers by Matthew I. Milowsky
This network shows the impact of papers produced by Matthew I. Milowsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew I. Milowsky. The network helps show where Matthew I. Milowsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew I. Milowsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 280 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology Hit paper breakdown → | 2014 | 640 |
| 2 | Genome Sequencing Identifies a Basis for Everolimus Sensitivity Hit paper breakdown → | 2012 | 504 |
| 3 | 2005 | 429 | |
| 4 | Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2013 | 331 |
| 5 | A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity Hit paper breakdown → | 2017 | 311 |
| 6 | 2004 | 255 | |
| 7 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma Hit paper breakdown → | 2020 | 235 |
| 8 | 2018 | 219 | |
| 9 | The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma Hit paper breakdown → | 2021 | 217 |
| 10 | 2003 | 207 | |
| 11 | 2018 | 206 | |
| 12 | 2008 | 202 | |
| 13 | Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline Hit paper breakdown → | 2022 | 193 |
| 14 | 2007 | 188 | |
| 15 | 2016 | 188 | |
| 16 | 2008 | 184 | |
| 17 | 2016 | 181 | |
| 18 | 2007 | 181 | |
| 19 | Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer Hit paper breakdown → | 2022 | 173 |
| 20 | 2012 | 173 |
About Matthew I. Milowsky
Matthew I. Milowsky is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Epidemiology, having authored 280 papers that have together received 10.8k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (175 papers), Urinary and Genital Oncology Studies (62 papers), Cancer Immunotherapy and Biomarkers (41 papers), Renal cell carcinoma treatment (37 papers), Prostate Cancer Treatment and Research (28 papers), Multiple and Secondary Primary Cancers (20 papers), Cancer Genomics and Diagnostics (12 papers) and Cancer Research and Treatments (10 papers). The work is most often cited by research in Surgery (5.2k citations), Pulmonary and Respiratory Medicine (3.0k citations), Oncology (2.4k citations), Urology (507 citations) and Cancer Research (934 citations). Matthew I. Milowsky has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include David M. Nanus, Neil H. Bander, Stanley J. Goldsmith, Dean F. Bajorin, Shankar Vallabhajosula, Lale Kostakoğlu, William Y. Kim, Gopa Iyer, Sara E. Wobker and Tracy L. Rose. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, The Journal of Urology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.